Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

3Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neither a high dose of the selective serotonin reuptake inhibitor citalopram (100 μmol kg-1s.c.), nor the 5-HT1Areceptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexane carboxamide 3HCl (WAY 100635) (0.1-0.4 μmol kg-1s.c.) produced any evidence of catalepsy in adult male rats. When combined with citalopram, however, WAY 100635 produced a dose-dependent, and statistically significant, catalepsy in the inclined grid test. © 2001 Elsevier Science B.V.

Cite

CITATION STYLE

APA

Eltayb, A., Svensson, T. H., & Ahlenius, S. (2001). Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram. European Journal of Pharmacology, 411(3), 275–277. https://doi.org/10.1016/S0014-2999(00)00924-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free